as 02-21-2025 4:00pm EST
Church & Dwight is the leading global producer of baking soda. Beyond baking soda, the products in its portfolio have vast category reach, including laundry products, cat litter, oral care, deodorant, and nasal care, all sold under the Arm & Hammer brand. Its mix also includes Batiste, OxiClean, Vitafusion, WaterPik, Hero, and TheraBreath, which together with Arm & Hammer constitute around 70% of its annual sales and profits. Even as it works to extend the reach of its products, Church & Dwight still derives more than 80% of its sales from its home market in the US.
Founded: | 1846 | Country: | United States |
Employees: | N/A | City: | EWING |
Market Cap: | 25.2B | IPO Year: | N/A |
Target Price: | $111.47 | AVG Volume (30 days): | 1.6M |
Analyst Decision: | Buy | Number of Analysts: | 17 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 2.37 | EPS Growth: | -22.30 |
52 Week Low/High: | $96.35 - $113.50 | Next Earning Date: | 01-31-2025 |
Revenue: | $6,107,100,000 | Revenue Growth: | 4.08% |
Revenue Growth (this year): | 4.04% | Revenue Growth (next year): | 3.78% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Read Michael | CHD | EVP, International | Dec 16 '24 | Buy | $106.82 | 1,900 | $202,963.49 | 1,400 | |
Saligram Ravichandra Krishnamurty | CHD | Director | Dec 16 '24 | Sell | $106.11 | 10,000 | $1,061,100.00 | 32,500 | |
Spann Rick | CHD | EVP Chief Supply Chain Officer | Dec 2 '24 | Sell | $112.00 | 39,520 | $4,426,240.00 | 4,973 |
CHD Breaking Stock News: Dive into CHD Ticker-Specific Updates for Smart Investing
MT Newswires
a day ago
Simply Wall St.
2 days ago
StockStory
2 days ago
StockStory
4 days ago
Business Wire
12 days ago
StockStory
13 days ago
Insider Monkey
13 days ago
Simply Wall St.
13 days ago
The information presented on this page, "CHD Church & Dwight Company Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.